MULTIPARAMETRIC TUMOR-MARKER ANALYSES (CA 19-9, CEA, UROKINASE-TYPE ANTIGEN) IN PLASMA OF PATIENTS WITH COLORECTAL-CANCER OR CROHNS-DISEASE

被引：0
|
作者：
HUBER, K
SEDLMAYER, A
KIRCHHEIMER, JC
RIMPFL, T
BINDER, BR
机构：
[1] VIENNA UNIV, DEPT CLIN EXPTL PHYSIOL, A-1090 VIENNA, AUSTRIA
[2] VIENNA UNIV, DEPT CARDIOL, A-1090 VIENNA, AUSTRIA
[3] VIENNA UNIV, DEPT GASTROENTEROL 2, A-1090 VIENNA, AUSTRIA
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [31] Assessment of prognostic values of serum CEA and CA 19-9 concentration in patients with colorectal cancer
    Tuteska, J.
    Arapceska, M.
    Stojkovski, V.
    Gligurovska, J.
    CLINICA CHIMICA ACTA, 2019, 493 : S121 - S121
  • [32] CLINICAL-EXPERIENCE WITH THE TUMOR-MARKER CA 19-9 IN AN UNSELECTED GROUP OF MORE THAN 300 TUMOR PATIENTS
    SOUCHON, R
    SOUCHON, MF
    BOESELANDGRAF, J
    BAER, U
    KOPPENHAGEN, K
    MATTHES, M
    FITZNER, R
    CANCER DETECTION AND PREVENTION, 1985, 8 (1-2): : 101 - 109
  • [33] CEA and CA 19-9 are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients
    Sisik, Abdullah
    Kaya, Mustafa
    Bas, Gurhan
    Basak, Fatih
    Alimoglu, Orhan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4289 - 4294
  • [34] Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection
    G. Bombski
    A. Gasiorowska
    D. Orszulak-Michalak
    B. Neneman
    J. Kotynia
    J. Strzelczyk
    A. Janiak
    E. Malecka-Panas
    International Journal of Colorectal Disease, 2003, 18 : 148 - 152
  • [35] Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection
    Bombski, G
    Gasiorowska, A
    Orszulak-Michalak, D
    Neneman, B
    Kotynia, J
    Strzelczyk, J
    Janiak, A
    Malecka-Panas, E
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (02) : 148 - 152
  • [36] THE NEW TUMOR-MARKER CA-72-4 IN COMPARISON WITH CA-19-9 AND CEA IN GASTROINTESTINAL-DISEASE
    HEPTNER, G
    DOMSCHKE, S
    SCHNEIDER, MU
    DOMSCHKE, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1988, 26 (09): : 598 - 598
  • [37] CA-242, A NEW TUMOR-MARKER FOR PANCREATIC-CANCER - A COMPARISON WITH CA-19-9, CA-50 AND CEA
    HAGLUND, C
    LUNDIN, J
    KUUSELA, P
    ROBERTS, PJ
    BRITISH JOURNAL OF CANCER, 1994, 70 (03) : 487 - 492
  • [38] Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer
    Boeck, Stefan
    Stieber, Petra
    Holdenrieder, Stefan
    Wilkowski, Ralf
    Heinemann, Volker
    ONCOLOGY, 2006, 70 (04) : 255 - 264
  • [39] Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer
    In Kyu Lee
    Do Hyoung Kim
    D. Lee Gorden
    Yoon Suk Lee
    Na Young Sung
    Gyeoung-Sin Park
    Hyung Jin Kim
    Won Kyung Kang
    Jong Kyung Park
    Chang Hyeok Ahn
    Jun-Gi Kim
    Hae Myung Jeon
    Seong Taek Oh
    Annals of Surgical Oncology, 2009, 16 : 861 - 870
  • [40] Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer
    Lee, In Kyu
    Kim, Do Hyoung
    Gorden, D. Lee
    Lee, Yoon Suk
    Sung, Na Young
    Park, Gyeoung-Sin
    Kim, Hyung Jin
    Kang, Won Kyung
    Park, Jong Kyung
    Ahn, Chang Hyeok
    Kim, Jun-Gi
    Jeon, Hae Myung
    Oh, Seong Taek
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) : 861 - 870
12345